{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:15Z","timestamp":1792184655185,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["453-12-001"],"award-info":[{"award-number":["453-12-001"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Individuals with a social anxiety disorder (SAD) show hypofunctioning of the hypothalamus\u2013pituitary-gonadal (HPG) axis, which is linked to social fear and avoidance behavior. As testosterone administration has been shown to facilitate social-approach behavior in this population, it may enhance the effectiveness of exposure treatment. In this proof-of-concept study, we performed a randomized clinical assay in which 55 women diagnosed with SAD received two exposure therapy sessions. Session 1 was supplemented with either testosterone (0.50\u2009mg) or placebo. Next, transfer effects of testosterone augmentation on within-session subjective fear responses and SAD symptom severity were assessed during a second, unenhanced exposure session (session 2) and at a 1-month follow-up, respectively. The participants having received testosterone showed a more reactive fear pattern, with higher peaks and steeper reductions in fear levels in session 2. Post-hoc exploration of moderating effects of endogenous testosterone levels, revealed that this pattern was specific for women with high basal testosterone, both in the augmented and in the transfer session. In contrast, the participants with low endogenous testosterone showed reduced peak fear levels throughout session 1, again with transfer to the unenhanced session. Testosterone did not significantly affect self-reported anxiety. The effects of testosterone supplementation on fear levels show transfer to non-enhanced exposure, with effects being modulated by endogenous testosterone. These first preliminary results indicate that testosterone may act on important fear mechanisms during exposure, providing the empirical groundwork for further exploration of multi-session testosterone-enhanced exposure treatment for SAD.<\/jats:p>","DOI":"10.1038\/s41398-021-01556-8","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T07:04:32Z","timestamp":1629443072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The enhancing effects of testosterone in exposure treatment for social anxiety disorder: a randomized proof-of-concept trial"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-7748","authenticated-orcid":false,"given":"Moniek H. M.","family":"Hutschemaekers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne A.","family":"de Kleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-9435","authenticated-orcid":false,"given":"Mirjam","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","volume":"17","author":"B Bandelow","year":"2015","unstructured":"Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17:327\u201335.","journal-title":"Dialogues Clin Neurosci"},{"key":"1556_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1176\/appi.ajp.162.6.1179","volume":"162","author":"SE Bruce","year":"2005","unstructured":"Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162:1179\u201387.","journal-title":"Am J Psychiatry"},{"key":"1556_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-016-0946-y","volume":"16","author":"SM Hendriks","year":"2016","unstructured":"Hendriks SM, Spijker J, Licht CM, Hardeveld F, de Graaf R, Batelaan NM, et al. Long-term disability in anxiety disorders. BMC Psychiatry. 2016;16:1\u20138.","journal-title":"BMC Psychiatry"},{"key":"1556_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brat.2017.04.004","volume":"96","author":"I Arnaudova","year":"2017","unstructured":"Arnaudova I, Kindt M, Fanselow M, Beckers T. Pathways towards the proliferation of avoidance in anxiety and implications for treatment. Behav Res Ther. 2017;96:3\u201313.","journal-title":"Behav Res Ther"},{"key":"1556_CR5","unstructured":"Clark D, Wells A. A cognitive model of social phobia. In: Social Phobia Diagnosis, Assessment and Treatment, Ch. 4 (The Guilford Press, New Yourk, 1995)."},{"key":"1556_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.22728","volume":"35","author":"JK Carpenter","year":"2018","unstructured":"Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits J, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35:502\u201314.","journal-title":"Depress Anxiety"},{"key":"1556_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4088\/JCP.v69n0415","volume":"69","author":"S Hofmann","year":"2008","unstructured":"Hofmann S, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo controlled trials. J Clin Psychiatry. 2008;69:621\u201332.","journal-title":"J Clin Psychiatry"},{"key":"1556_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2018.08.016","volume":"242","author":"KS Young","year":"2019","unstructured":"Young KS, LeBeau RT, Niles AN, Hsu KJ, Burklund LJ, Mesri B, et al. Neural connectivity during affect labeling predicts treatment response to psychological therapies for social anxiety disorder. J Affect Disord. 2019;242:105\u201310.","journal-title":"J Affect Disord"},{"key":"1556_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cpr.2015.08.004","volume":"42","author":"AG Loerinc","year":"2015","unstructured":"Loerinc AG, Meuret AE, Twohig MP, Rosenfield D, Bluett EJ, Craske MG. Response rates for CBT for anxiety disorders: need for standardized criteria. Clin Psychol Rev. 2015;42:72\u201382.","journal-title":"Clin Psychol Rev"},{"key":"1556_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.biopsych.2013.10.008","volume":"75","author":"JA Smits","year":"2014","unstructured":"Smits JA, Rosenfield D, Davis ML, Julian K, Handelsman PR, Otto MW, et al. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biol Psychiatry. 2014;75:840\u20136.","journal-title":"Biol Psychiatry."},{"key":"1556_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.brat.2006.07.005","volume":"45","author":"AJ Guastella","year":"2007","unstructured":"Guastella AJ, Lovibond PF, Dadds MR, Mitchell P, Richardson R. A randomized controlled trial of the effect of d-cycloserine on extinction and fear conditioning in humans. Behav Res Ther. 2007;45:663\u201372.","journal-title":"Behav Res Ther"},{"key":"1556_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","volume":"63","author":"SG Hofmann","year":"2006","unstructured":"Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K. et al. Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006;63:298\u2013304.","journal-title":"Arch Gen Psychiatry"},{"key":"1556_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/da.22047","volume":"30","author":"TL Rodebaugh","year":"2013","unstructured":"Rodebaugh TL, Levinson CA, Lenze EJ. A high-throughput clinical assay for testing drug facilitation of exposure therapy. Depress Anxiety. 2013;30:631\u20137.","journal-title":"Depress Anxiety"},{"key":"1556_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2020.6777","volume":"3","author":"JAJ Smits","year":"2020","unstructured":"Smits JAJ, Pollack MH, Rosenfield D, Otto MW, Dowd S, Carpenter J, et al. Dose timing of D-cycloserine to augment exposure therapy for social anxiety disorder a randomized clinical trial. JAMA Netw Open. 2020;3:1\u201313.","journal-title":"JAMA Netw Open"},{"key":"1556_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.psyneuen.2009.01.005","volume":"34","author":"AJ Guastella","year":"2009","unstructured":"Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 2009;34:917\u201323.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13546800500213993","volume":"11","author":"EJ Hermans","year":"2006","unstructured":"Hermans EJ, Honk Van J. Toward a framework for defective emotion processing in social phobia. Cogn Neuropsychiatry. 2006;11:307\u201331.","journal-title":"Cogn Neuropsychiatry"},{"key":"1556_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neubiorev.2004.12.007","volume":"30","author":"J Archer","year":"2006","unstructured":"Archer J. Testosterone and human aggression: an evaluation of the challenge hypothesis. Neurosci Biobehav Rev. 2006;30:319\u201345.","journal-title":"Neurosci Biobehav Rev"},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1037\/0022-3514.90.6.999","volume":"90","author":"RA Josephs","year":"2006","unstructured":"Josephs RA, Sellers JG, Newman ML, Mehta PH. The mismatch effect: when testosterone and status are at odds. J Pers Soc Psychol. 2006;90:999\u20131013.","journal-title":"J Pers Soc Psychol"},{"key":"1556_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0306-4530(91)90015-L","volume":"16","author":"RM Sapolsky","year":"1991","unstructured":"Sapolsky RM. Testicular function, social rank and personality among wild baboons. Psychoneuroendocrinology. 1991;16:281\u201393.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1467-9280.2008.02154.x","volume":"19","author":"JK Maner","year":"2008","unstructured":"Maner JK, Miller SL, Schmidt NB, Eckel LA. Submitting to defeat. Psychol Sci. 2008;19:764\u20138.","journal-title":"Psychol Sci"},{"key":"1556_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1017\/S0140525X98001228","volume":"21","author":"A Mazur","year":"1998","unstructured":"Mazur A, Booth A. Testosterone and dominance in men. Behav Brain Sci. 1998;21:353\u201397.","journal-title":"Behav Brain Sci"},{"key":"1556_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpsychores.2011.11.014","volume":"72","author":"EJ Giltay","year":"2012","unstructured":"Giltay EJ, Enter D, Zitman FG, Penninx BW, van Pelt J, Spinhoven P, et al. Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study. J Psychosom Res. 2012;72:205\u201313.","journal-title":"J Psychosom Res"},{"key":"1556_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/archgenpsychiatry.2007.33","volume":"65","author":"OP Almeida","year":"2008","unstructured":"Almeida OP, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry. 2008;65:283\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"1556_CR24","doi-asserted-by":"publisher","first-page":"104612.","DOI":"10.1016\/j.psyneuen.2020.104612","volume":"115","author":"MHM Hutschemaekers","year":"2020","unstructured":"Hutschemaekers MHM, de Kleine RA, Davis ML, Kampman M, Smits J, Roelofs K. Endogenous testosterone levels are predictive of symptom reduction with exposure therapy in social anxiety disorder. Psychoneuroendocrinology. 2020;115:104612.","journal-title":"Psychoneuroendocrinology."},{"key":"1556_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.psyneuen.2016.07.203","volume":"72","author":"D Terburg","year":"2016","unstructured":"Terburg D, Syal S, Rosenberger LA, Heany SJ, Stein DJ, Honk JV. Testosterone abolishes implicit subordination in social anxiety. Psychoneuroendocrinology. 2016;72:205\u201311.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.yhbeh.2014.02.001","volume":"65","author":"D Enter","year":"2014","unstructured":"Enter D, Spinhoven P, Roelofs K. Alleviating social avoidance: effects of single dose testosterone administration on approach-avoidance action. Horm Behav. 2014;65:351\u20134.","journal-title":"Horm Behav"},{"key":"1556_CR27","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1177\/2167702616631499","volume":"4","author":"D Enter","year":"2016","unstructured":"Enter D, Spinhoven P, Roelofs K. Dare to approach: single dose testosterone administration promotes threat approach in patients with social anxiety disorder. Clin Psychol Sci. 2016;4:1073\u20139.","journal-title":"Clin Psychol Sci"},{"key":"1556_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuroimage.2010.04.019","volume":"52","author":"EJ Hermans","year":"2010","unstructured":"Hermans EJ, Bos PA, Ossewaarde L, Ramsey NF, Fern\u00e1ndez G, van Honk J. Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women. Neuroimage. 2010;52:277\u201383.","journal-title":"Neuroimage"},{"key":"1556_CR29","doi-asserted-by":"publisher","first-page":"e1400074","DOI":"10.1126\/sciadv.1400074","volume":"1","author":"S Radke","year":"2015","unstructured":"Radke S, Volman I, Mehta P, van Son V, Enter D, Sanfey A, et al. Testosterone biases the amygdala toward social threat approach. Sci Adv. 2015;1:e1400074.","journal-title":"Sci Adv"},{"key":"1556_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yfrne.2011.01.002","volume":"33","author":"PA Bos","year":"2012","unstructured":"Bos PA, Panksepp J, Bluth\u00e9 RM, van Honk J. Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies. Front Neuroendocrinol. 2012;33:17\u201335.","journal-title":"Front Neuroendocrinol"},{"key":"1556_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.psyneuen.2015.09.008","volume":"63","author":"D Enter","year":"2016","unstructured":"Enter D, Terburg D, Harrewijn A, Spinhoven P, Roelofs K. Single dose testosterone administration alleviates gaze avoidance in women with social anxiety disorder. Psychoneuroendocrinology. 2016;63:26\u201333.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsycho.2017.08.003","volume":"129","author":"JM van Peer","year":"2017","unstructured":"van Peer JM, Enter D, van Steenbergen H, Spinhoven P, Roelofs K. Exogenous testosterone affects early threat processing in socially anxious and healthy women. Biol Psychol. 2017;129:82\u20139.","journal-title":"Biol Psychol"},{"key":"1556_CR33","doi-asserted-by":"crossref","unstructured":"Enter D, Hutschemaekers MHM, Roelofs K. Neuroendocrinological aspects of social anxiety and aggression-related disorders. In: Schultheiss OC, Mehta PH, editors. Routledge international handbook of social neuroendocrinology. Ch. 34. Abingdon: Routledge; 2018, p. 635\u201355.","DOI":"10.4324\/9781315200439-35"},{"key":"1556_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1037\/0033-2909.99.1.20","volume":"99","author":"EB Foa","year":"1986","unstructured":"Foa EB, Kozak MJ. Emotional processing of fear. Exposure to corrective information. Psychol Bull. 1986;99:20\u201335.","journal-title":"Psychol Bull"},{"key":"1556_CR35","unstructured":"Foa, E, Huppert, JD, Cahill, SP. Emotional processing theory: an update. In: Rothbaum BO, editor. The nature and treatment of pathological anxiety. New York, NY: The Guilford Press; 2005, p. 3\u201324."},{"key":"1556_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.brat.2007.10.003","volume":"46","author":"MG Craske","year":"2008","unstructured":"Craske MG, Kircanski K, Zelikowsky M, Mystkowski J, Chowdhury N, Baker A. Optimizing inhibitory learning during exposure therapy. Behav Res Ther. 2008;46:5\u201327.","journal-title":"Behav Res Ther"},{"key":"1556_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.psyneuen.2015.11.016","volume":"64","author":"LLM Welling","year":"2016","unstructured":"Welling LLM, Moreau BJP, Bird BM, Hansen S, Carr\u00e9 JM. Exogenous testosterone increases men\u2019s perceptions of their own physical dominance. Psychoneuroendocrinology. 2016;64:136\u201342.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR38","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1073\/pnas.1011891108","volume":"108","author":"J van Honk","year":"2011","unstructured":"van Honk J, Schutter DJ, Bos PA, Kruijt AW, Lentjes EG, Baron-Cohen S. Testosterone administration impairs cognitive empathy in women depending on second-to-fourth digit ratio. Proc Natl Acad Sci USA. 2011;108:3448\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1556_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.psyneuen.2015.08.023","volume":"62","author":"JM Carr\u00e9","year":"2015","unstructured":"Carr\u00e9 JM, Ortiz TL, Labine B, Moreau BJ, Viding E, Neumann CS, et al. Digit ratio (2D:4D) and psychopathic traits moderate the effect of exogenous testosterone on socio-cognitive processes in men. Psychoneuroendocrinology. 2015;62:319\u201326.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR40","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333.","journal-title":"J Clin Psychiatry."},{"key":"1556_CR41","doi-asserted-by":"crossref","unstructured":"Liebowitz, MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141\u201373.","DOI":"10.1159\/000414022"},{"key":"1556_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/archpsyc.57.2.149","volume":"57","author":"A Tuiten","year":"2000","unstructured":"Tuiten A, Van Honk J, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry. 2000;57:149\u201353.","journal-title":"Arch Gen Psychiatry"},{"key":"1556_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.psyneuen.2011.09.008","volume":"37","author":"K van Rooij","year":"2012","unstructured":"van Rooij K, Bloemers J, de Leede L, Goldstein I, Lentjes E, Koppeschaar H, et al. Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women. Psychoneuroendocrinology. 2012;37:773\u201381.","journal-title":"Psychoneuroendocrinology"},{"key":"1556_CR44","first-page":"253","volume":"16","author":"J Wolpe","year":"1966","unstructured":"Wolpe J, Lazarus AA. Behavior therapy techniques: a guide to the treatment of neuroses. Arch Gen Psychiatry. 1966;16:253\u20134.","journal-title":"Arch Gen Psychiatry"},{"key":"1556_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0005-7967(97)10031-6","volume":"36","author":"RP Mattick","year":"1998","unstructured":"Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998;36:455\u201370.","journal-title":"Behav Res Ther"},{"key":"1556_CR46","doi-asserted-by":"publisher","first-page":"360193.","DOI":"10.1155\/2014\/360193","volume":"2014","author":"E De Beurs","year":"2014","unstructured":"De Beurs E, Tielen D, Wollmann L. The Dutch social interaction anxiety scale and the social phobia scale: reliability, validity, and clinical utility. Psychiatry J.2014;2014:360193.","journal-title":"Psychiatry J."},{"key":"1556_CR47","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/PSY.0000000000000002","volume":"75","author":"R Miller","year":"2013","unstructured":"Miller R, Plessow F, Kirschbaum C, Stalder T. Classification criteria for distinguishing cortisol responders from nonresponders to psychosocial stress. Psychosom Med. 2013;75:832\u201340.","journal-title":"Psychosom Med"},{"key":"1556_CR48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jora.12198","volume":"26","author":"KW Reardon","year":"2016","unstructured":"Reardon KW, Herzhoff K, Tackett JL. Adolescent personality as risk and resiliency in the testosterone\u2013externalizing association. J Res Adolesc. 2016;26:390\u2013402.","journal-title":"J Res Adolesc"},{"key":"1556_CR49","unstructured":"Bates, D, Maechler, M, Bolker, B, Walker, S. lme4: linear mixed-effects models using Eigen and S4. R package. 1.0-5. 2013."},{"key":"1556_CR50","doi-asserted-by":"crossref","unstructured":"Singmann H. Afex: Analysis of factorial experiments. R package version. 0.7\u201390. 2013.","DOI":"10.32614\/CRAN.package.afex"},{"key":"1556_CR51","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1037\/met0000126","volume":"23","author":"J Pek","year":"2018","unstructured":"Pek J, Flora DB. Reporting effect sizes in original psychological research. Psychol Methods. 2018;23:208\u201325.","journal-title":"Psychol Methods"},{"key":"1556_CR52","doi-asserted-by":"publisher","first-page":"104754","DOI":"10.1016\/j.yhbeh.2020.104754","volume":"122","author":"JM Carr\u00e9","year":"2020","unstructured":"Carr\u00e9 JM, Robinson BA. Testosterone administration in human social neuroendocrinology: past, present, and future. Horm Behav. 2020;122:104754.","journal-title":"Horm Behav"},{"key":"1556_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yhbeh.2018.06.001","volume":"104","author":"SN Geniole","year":"2018","unstructured":"Geniole SN, Carr\u00e9 JM. Human social neuroendocrinology: review of the rapid effects of testosterone. Horm Behav. 2018;104:192\u2013205.","journal-title":"Horm Behav"},{"key":"1556_CR54","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.biopsych.2005.11.015","volume":"59","author":"EJ Hermans","year":"2006","unstructured":"Hermans EJ, Putman P, Baas JM, Koppeschaar HP, van Honk J. A single administration of testosterone reduces fear-potentiated startle in humans. Biol Psychiatry. 2006;59:872\u20134.","journal-title":"Biol Psychiatry"},{"key":"1556_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brat.2014.04.006","volume":"58","author":"MG Craske","year":"2014","unstructured":"Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10\u201323.","journal-title":"Behav Res Ther"},{"key":"1556_CR56","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/156800705774322049","volume":"4","author":"E Hogervorst","year":"2005","unstructured":"Hogervorst E, Bandelow S, Moffat SD. Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review. CNS Neurol Disord Drug Targets. 2005;4:531\u201340.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1556_CR57","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.maturitas.2011.05.012","volume":"69","author":"J Holland","year":"2011","unstructured":"Holland J, Bandelow S, Hogervorst E. Testosterone levels and cognition in elderly men: a review. Maturitas. 2011;69:322\u201337.","journal-title":"Maturitas"},{"key":"1556_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1365-2265.2004.02173.x","volume":"62","author":"MA Sader","year":"2005","unstructured":"Sader MA, McGrath KC, Hill MD, Bradstock KF, Jimenez M, Handelsman DJ, et al. Androgen receptor gene expression in leucocytes is hormonally regulated: Implications for gender differences in disease pathogenesis. Clin Endocrinol. 2005;62:56\u201363.","journal-title":"Clin Endocrinol"},{"key":"1556_CR59","doi-asserted-by":"publisher","unstructured":"Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, de la Cruz LF, Andersson E, et al. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 68102149. https:\/\/doi.org\/10.1016\/j.janxdis.2019.102149.","DOI":"10.1016\/j.janxdis.2019.102149"},{"key":"1556_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0223729","volume":"14","author":"SG Hofmann","year":"2019","unstructured":"Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, et al. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS ONE. 2019;14:1\u201314.","journal-title":"PLoS ONE"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01556-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:14:39Z","timestamp":1725664479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01556-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01556-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"28 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}